Assessing coronary heart disease risk with traditional and novel risk factors

Clinical Cardiology
Peter W F Wilson

Abstract

Cardiovascular disease is the leading cause of death in the industrialized world, and a number of well-characterized factors, including advanced age, hypertension, dyslipidemia, diabetes, and smoking, contribute to cardiovascular risk. Integration of these factors using the Framingham calculation estimates the absolute 10-year risk for coronary heart disease (CHD), which can be used to guide therapy. Recent studies have demonstrated that additional markers, including elevated lipoprotein(a), homocysteine, sitosterol, and particularly C-reactive protein (CRP), are also associated with increased risk for CHD. In particular, high-sensitivity CRP has been shown to identify patients with high CHD risk who may not have elevated low-density lipoprotein cholesterol (LDL-C) and may add to the predictive value of the Framingham functions for CHD risk assessment. Assessment of global risk is particularly important in lipid management, as the LDL-C target goals are determined by risk category.

References

Jan 1, 1990·Journal of the American College of Cardiology·W B Kannel
Apr 6, 1994·JAMA : the Journal of the American Medical Association·E J SchaeferR I Levy
Mar 8, 1993·Archives of Internal Medicine·J StamlerJ D Neaton
May 29, 1998·Circulation·P W WilsonW B Kannel
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P W Wilson
Mar 1, 2000·Archives of Internal Medicine·W G ChristenC H Hennekens
Oct 29, 2000·The American Journal of Cardiology·P Cullen
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 13, 2001·JAMA : the Journal of the American Medical Association·R B D'AgostinoUNKNOWN CHD Risk Prediction Group
Dec 6, 2001·Annals of Clinical Biochemistry·R Clarke, D Stansbie
Mar 2, 2002·The American Journal of Geriatric Cardiology·William B Kannel
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Dec 19, 2002·Metabolism: Clinical and Experimental·Thomas SudhopKlaus von Bergmann
Mar 12, 2003·Critical Reviews in Clinical Laboratory Sciences·Giuseppe Lippi, Giancesare Guidi
Apr 16, 2003·Kidney International. Supplement·Alessandra F PernaNatale G De Santo
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Philip GreenlandPeter W Wilson
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Umesh N KhotEric J Topol
Sep 10, 2003·Archives of Internal Medicine·Donald M Lloyd-JonesDaniel Levy

❮ Previous
Next ❯

Citations

Sep 1, 2006·Reviews in Endocrine & Metabolic Disorders·Mark L Johnson, Nalini Rajamannan
Sep 29, 2006·International Urology and Nephrology·Konstantinos N StamatiouFragiskos Sofras
Jun 17, 2009·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Raja Shekhar R Sappati BiyyaniJames F King
Dec 25, 2009·Circulation. Cardiovascular Genetics·Dolores Corella, Jose M Ordovas
Oct 7, 2008·Journal of Periodontology·Ira B Lamster, Dana L Wolf
May 27, 2010·Journal of Clinical Nursing·Sara M G BrandãoLuís H W Gowdak
Mar 11, 2017·Clinical Oral Investigations·Eduardo Zaccarias CuryPoliana Mendes Duarte
Sep 27, 2006·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Umed A AjaniLisa C McGuire
Dec 30, 2017·Kidney Research and Clinical Practice·Muhammad A SiddiquiThomas Carline
Apr 15, 2011·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Scott HaskinsRebecca L Koscik
Mar 28, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinji FukuharaYuzuru Sakakibara
Jan 16, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zhen-Hong XiaYan-Qiang Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.